Biotechnology industry-physician interaction and OIG guidelines: Evidence from the stock market

Author： Jambulingam Thani Ghani WaQar Sharma Rajneesh

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.16, Iss.4, 2010-10, pp. : 313-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Taking stock in biotechnology futures

By Jacobs John L

Journal of Commercial Biotechnology, Vol. 12, Iss. 1, 2005-10 ,pp. : 58-60

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

The Atlantic divide in food biotechnology: differences in industry, market and consumers' perception between the USA and the UK

By Gurau Calin Ranchhod Ashok

International Journal of Biotechnology, Vol. 5, Iss. 2, 2003-09 ,pp. : 141-156

Inderscience Publishers

Access to resources Recommend Favorite

Downstream processing in the biotechnology industry

By Kalyanpur Manohar

Molecular Biotechnology, Vol. 22, Iss. 1, 2002-09 ,pp. : 87-98

Humana Press, Inc

Access to resources Recommend Favorite

The state of the US biotechnology industry

By Bullock W.O. Dibner M.D.

Trends in Biotechnology, Vol. 13, Iss. 11, 1995-11 ,pp. : 463-467

Elsevier

Access to resources Recommend Favorite

The evolution of the biotechnology industry in Germany

By Muller C.

Trends in Biotechnology, Vol. 20, Iss. 7, 2002-07 ,pp. : 287-290

Elsevier

Access to resources Recommend Favorite